文献速递腹部介入CT

利用治疗前CT预测经动脉化疗栓塞治疗肝细胞癌患者的生存:基于影像组学的模型比较

Predicting Survival Using Pretreatment CT for Patients With Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: Comparison of Models Using Radiomics.
PubMed 文献 · AJR Am J Roentgenol · 2018-09-21

该回顾性研究纳入88例接受经动脉化疗栓塞(TACE)的肝细胞癌(HCC)患者,从治疗前CT提取116个影像组学特征构建影像组学评分模型,并结合Child-Pugh评分、甲胎蛋白水平和HCC大小构建临床评分模型及联合评分模型,发现联合模型对总生存的预测优于临床或影像组学单一模型(风险比19.88,p<0.0001)。

要点

  • 联合模型(5个影像组学特征+3个临床因素)预测生存的风险比为19.88(p<0.0001),优于单一模型。
  • 影像组学评分模型纳入直方图、形状、灰度共生矩阵和强度大小区域矩阵等特征。
  • 临床评分模型包含Child-Pugh评分、甲胎蛋白水平和HCC大小。

核心结论

  • 影像组学方法联合常规临床变量可能有效预测接受TACE治疗的HCC患者的生存。

研究设计与样本

  • 回顾性分析88例接受TACE治疗的HCC患者,从治疗前CT提取116个影像组学特征。
  • 采用最小绝对收缩和选择算子Cox回归构建影像组学评分模型,多因素Cox回归构建临床评分模型,并联合两者构建联合评分模型。
  • 使用Kaplan-Meier分析和log-rank检验比较三种模型对总生存的预测。

诊断标准与关键数值

  • 影像组学评分模型纳入特征:直方图特征(中位数、峰度、能量)、形状特征(球形不比例、表面积体积比)、灰度共生矩阵特征(能量、相关信息度量、最大概率、对比度、和平均)、强度大小区域矩阵特征(大小区域变异性)。
  • 临床评分模型纳入:Child-Pugh评分、甲胎蛋白水平、HCC大小。
  • 联合评分模型纳入五个影像组学特征(表面积体积比、峰度、中位数、灰度共生矩阵对比度、大小区域变异性)和三个临床因素(Child-Pugh评分、甲胎蛋白水平、HCC大小)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The purpose of this study was to investigate the use of radiomics features as prognostic biomarkers for predicting the survival of patients treated with transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC).

MATERIALS AND METHODS: We retrospectively analyzed 88 patients with HCC treated with TACE. High-dimensional quantitative feature analysis was applied to extract 116 radiomics features of pretreatment CT. A radiomics score model was constructed from these features with the use of least absolute shrinkage and selection operator Cox regression. A clinical score model was constructed from clinical variables with the use of multivariate Cox regression. A combined score model was constructed using the radiomics and clinical models. We compared the three models (the radiomics score, clinical score, and combined score models) for predicting overall survival, using Kaplan-Meier analysis and the log-rank test.

RESULTS: The following radiomics features were selected for the radiomics score model: histogram-based features (median, kurtosis, and energy), shape-based features (spherical disproportion and surface-to-volume ratio), gray-level co-occurrence matrix (GLCM)-based features (energy, informational measure of correlation, maximum probability, contrast, and sum average), and intensity size zone matrix-based features (size zone variability). For the clinical score model, the Child-Pugh score, α-fetoprotein level, and HCC size were included. The combined score model included five radiomics features (surface area-to-volume ratio, kurtosis, median, gray-level co-occurrence matrix contrast, and size zone variability) and three clinical factors (Child-Pugh score, α-fetoprotein level, and HCC size). The combined model was a better predictor of survival (hazard ratio, 19.88; p < 0.0001) than the clinical score model or the radiomics score model.

CONCLUSION: A radiomics approach combined with conventional clinical variables could be effective in predicting the survival of patients with HCC treated with TACE.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Kim J, Choi SJ, Lee SH, et al. Predicting Survival Using Pretreatment CT for Patients With Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: Comparison of Models Using Radiomics. AJR Am J Roentgenol. 2018. PMID: 30240304. doi:10.2214/AJR.18.19507

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。